{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:18:53Z","timestamp":1775798333796,"version":"3.50.1"},"reference-count":66,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>The global burden of respiratory viral infections is notable, which is attributed to their higher transmissibility compared to other viral diseases. Respiratory viruses are seen to have evolved resistance to available treatment options. Although vaccines and antiviral drugs control some respiratory viruses, this control is limited due to unexpected events, such as mutations and the development of antiviral resistance. The technology of proteolysis-targeting chimeras (PROTACs) has been emerging as a novel technology in viral therapeutics. These are small molecules that can selectively degrade target proteins via the ubiquitin\u2013proteasome pathway. PROTACs as a therapy were initially developed against cancer, but they have recently shown promising results in their antiviral mechanisms by targeting viral and\/or host proteins involved in the pathogenesis of viral infections. In this review, we elaborate on the antiviral potential of PROTACs as therapeutic agents and their potential as vaccine components against important respiratory viral pathogens, including influenza viruses, coronaviruses (SARS-CoV-2), and respiratory syncytial virus. Advanced applications of PROTAC antiviral strategies, such as hemagglutinin and neuraminidase degraders for influenza and spike proteins of SARS-CoV-2, are detailed in this review. Additionally, the role of PROTACs in targeting cellular mechanisms within the host, thereby preventing viral pathogenesis and eliciting an antiviral effect, is discussed. The potential of PROTACs as vaccines, utilizing proteasome-based virus attenuation to achieve a robust protective immune response, while ensuring safety and enhancing efficient production, is also presented. With the promises exhibited by PROTACs, this technology faces significant challenges, including the emergence of novel viral strains, tissue-specific expression of E3 ligases, and pharmacokinetic constraints. With advanced computational design in molecular platforms, PROTAC-based antiviral development offers an alternative, transformative path in tackling respiratory viruses.<\/jats:p>","DOI":"10.3390\/microorganisms13071557","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:35:52Z","timestamp":1751517352000},"page":"1557","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PROTAC-Based Antivirals for Respiratory Viruses: A Novel Approach for Targeted Therapy and Vaccine Development"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1351-1358","authenticated-orcid":false,"given":"Amith","family":"Anugu","sequence":"first","affiliation":[{"name":"Basic Medical Science, American University of Antigua College of Medicine, St. Johns 1543, Antigua and Barbuda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Singh","sequence":"additional","affiliation":[{"name":"ICMR-National Institute for One Health, Nagpur, Maharashtra 440006, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9160-9377","authenticated-orcid":false,"given":"Dharambir","family":"Kashyap","sequence":"additional","affiliation":[{"name":"Brown Center for Immunotherapy, Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillwin","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, American University of Antigua College of Medicine, St. Johns 1543, Antigua and Barbuda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheetal","family":"Naik","sequence":"additional","affiliation":[{"name":"Department of Physiology, American University of Antigua College of Medicine, St. Johns 1543, Antigua and Barbuda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhabrata","family":"Sarkar","sequence":"additional","affiliation":[{"name":"Department of Virology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0172-7423","authenticated-orcid":false,"given":"Kamran","family":"Zaman","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Biology, ICMR-National Institute of Traditional Medicine, Belagavi 590010, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manpreet","family":"Dhaliwal","sequence":"additional","affiliation":[{"name":"Allergy and Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubham","family":"Nagar","sequence":"additional","affiliation":[{"name":"Basic Medical Science, American University of Antigua College of Medicine, St. Johns 1543, Antigua and Barbuda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanishq","family":"Gupta","sequence":"additional","affiliation":[{"name":"Basic Medical Science, American University of Antigua College of Medicine, St. Johns 1543, Antigua and Barbuda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-4242","authenticated-orcid":false,"given":"Prasanna","family":"Honnavar","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, American University of Antigua College of Medicine, St. Johns 1543, Antigua and Barbuda"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Weston, S., and Frieman, M.B. (2018). Respiratory Viruses. Reference Module in Biomedical Sciences, Elsevier.","DOI":"10.1016\/B978-0-12-801238-3.66161-5"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/01.PDR.0000129184.87042.FC","article-title":"SARS: The First Pandemic of the 21st Century","volume":"56","author":"Cherry","year":"2004","journal-title":"Pediatr. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.idc.2019.08.001","article-title":"The Middle East Respiratory Syndrome (MERS)","volume":"33","author":"Azhar","year":"2019","journal-title":"Infect. Dis. Clin. North. Am."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Acuti Martellucci, C., Flacco, M.E., Cappadona, R., Bravi, F., Mantovani, L., and Manzoli, L. (2020). SARS-CoV-2 pandemic: An overview. Adv. Biol. Regul., 77.","DOI":"10.1016\/j.jbior.2020.100736"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Charostad, J., Rezaei Zadeh Rukerd, M., Mahmoudvand, S., Bashash, D., Hashemi, S.M.A., Nakhaie, M., and Zandi, K. (2023). A comprehensive review of highly pathogenic avian influenza (HPAI) H5N1: An imminent threat at doorstep. Travel. Med. Infect. Dis., 55.","DOI":"10.1016\/j.tmaid.2023.102638"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","article-title":"Influenza and antiviral resistance: An overview","volume":"39","author":"Lampejo","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/acsmedchemlett.9b00597","article-title":"PROTAC Technology: Opportunities and Challenges","volume":"11","author":"Gao","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Sun, X., Gao, H., Yang, Y., He, M., Wu, Y., Song, Y., Tong, Y., and Rao, Y. (2019). PROTACs: Great opportunities for academia and industry. Sig Transduct. Target. Ther., 4.","DOI":"10.1038\/s41392-019-0101-6"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41587-021-01173-2","article-title":"The PROTAC gold rush","volume":"40","author":"Garber","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.chembiol.2021.04.011","article-title":"Targeted Protein Degradation: A Promise for Undruggable Proteins","volume":"28","author":"Samarasinghe","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Desantis, J., Mercorelli, B., Celegato, M., Croci, F., Bazzacco, A., Baroni, M., Siragusa, L., Cruciani, G., Loregian, A., and Goracci, L. (2021). Indomethacin-based PROTACs as pan-coronavirus antiviral agents. Eur. J. Med. Chem., 226.","DOI":"10.1016\/j.ejmech.2021.113814"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Xu, Z., Liu, X., Ma, X., Zou, W., Chen, Q., Chen, F., Deng, X., Liang, J., Dong, C., and Lan, K. (2022). Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus. Cell Insight, 1.","DOI":"10.1016\/j.cellin.2022.100030"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"de Wispelaere, M., Du, G., Donovan, K.A., Zhang, T., Eleuteri, N.A., Yuan, J.C., Kalabathula, J., Nowak, R.P., Fischer, E.S., and Gray, N.S. (2019). Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations. Nat. Commun., 10.","DOI":"10.1038\/s41467-019-11429-w"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Pravin, N., and J\u00f3\u017awiak, K. (2024). PROTAC unleashed: Unveiling the synthetic approaches and potential therapeutic applications. Eur. J. Med. Chem., 279.","DOI":"10.1016\/j.ejmech.2024.116837"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.37349\/etat.2020.00018","article-title":"Current strategies for the design of PROTAC linkers: A critical review","volume":"1","author":"Troup","year":"2020","journal-title":"Explor. Target. Antitumor Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1021\/acs.jmedchem.6b01781","article-title":"A \u201cClick Chemistry Platform\u201d for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation","volume":"61","author":"Wurz","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Xu, H., Kurohara, T., Takano, R., Yokoo, H., Shibata, N., Ohoka, N., Inoue, T., Naito, M., and Demizu, Y. (2022). Development of Rapid and Facile Solid-Phase Synthesis of PROTACs via a Variety of Binding Styles. ChemistryOpen, 11.","DOI":"10.1002\/open.202200131"},{"key":"ref_18","unstructured":"(2025, June 20). Rapid PROTAC Discovery Platform: Nanomole-Scale Array Synthesis and Direct Screening of Reaction Mixtures|ACS Medicinal Chemistry Letters. Available online: https:\/\/pubs.acs.org\/doi\/10.1021\/acsmedchemlett.3c00314."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1039\/D0CC05395C","article-title":"Traceless Staudinger ligation enabled parallel synthesis of proteolysis targeting chimera linker variants","volume":"57","author":"Bemis","year":"2021","journal-title":"Chem. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1021\/acs.jcim.8b00350","article-title":"Protein Family-Specific Models Using Deep Neural Networks and Transfer Learning Improve Virtual Screening and Highlight the Need for More Data","volume":"58","author":"Imrie","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1039\/D0SC03126G","article-title":"SyntaLinker: Automatic fragment linking with deep conditional transformer neural networks","volume":"11","author":"Yang","year":"2020","journal-title":"Chem. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/bs.mie.2023.06.020","article-title":"Chapter Ten\u2014Methods for computer-assisted PROTAC design","volume":"Volume 690","author":"Lloyd","year":"2023","journal-title":"Methods in Enzymology"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Fermin, G. (2018). Virion Structure, Genome Organization, and Taxonomy of Viruses. Viruses, Academic Press.","DOI":"10.1016\/B978-0-12-811257-1.00002-4"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Louten, J. (2016). Virus Replication. Essent. Human. Virol., 49\u201370.","DOI":"10.1016\/B978-0-12-800947-5.00004-1"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Millet, J.K., Jaimes, J.A., and Whittaker, G.R. (2020). Molecular diversity of coronavirus host cell entry receptors. FEMS Microbiol. Rev., 45.","DOI":"10.1093\/femsre\/fuaa057"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Byrd-Leotis, L., Cummings, R.D., and Steinhauer, D.A. (2017). The Interplay between the Host Receptor and Influenza Virus Hemagglutinin and Neuraminidase. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071541"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: Chimeric molecules that target proteins to the Skp1\u2013Cullin\u2013F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-024-02024-9","article-title":"New-generation advanced PROTACs as potential therapeutic agents in cancer therapy","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Petrylak, D.P., Gao, X., Vogelzang, N.J., Garfield, M.H., Taylor, I., Moore, M.D., Peck, R.A., and Burris, H.A. (2020). First-in-Human Phase I Study of ARV-110, an Androgen Receptor (AR) PROTAC Degrader in Patients (pts) with Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Following Enzalutamide (ENZ) and\/or Abiraterone (ABI). J. Clin. Oncol., 38.","DOI":"10.1200\/JCO.2020.38.15_suppl.3500"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Nelson, P.P., Papadopoulos, N.G., and Skevaki, C. (2022). Respiratory Viral Pathogens. Encyclopedia of Respiratory Medicine, Elsevier.","DOI":"10.1016\/B978-0-12-801238-3.11635-6"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1021\/acs.jmedchem.1c02013","article-title":"Discovery of Pentacyclic Triterpenoid PROTACs as a Class of Effective Hemagglutinin Protein Degraders","volume":"65","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhao, J., Wang, J., Pang, X., Liu, Z., Li, Q., Yi, D., Zhang, Y., Fang, X., Zhang, T., and Zhou, R. (2022). An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA. Nat. Commun., 13.","DOI":"10.1038\/s41467-022-29690-x"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"McAuley, J.L., Gilbertson, B.P., Trifkovic, S., Brown, L.E., and McKimm-Breschkin, J.L. (2019). Influenza Virus Neuraminidase Structure and Functions. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.00039"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s40506-017-0129-5","article-title":"Antiviral Drugs for the Treatment and Prevention of Influenza","volume":"9","author":"Farrukee","year":"2017","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Naqvi, A.A.T., Fatima, K., Mohammad, T., Fatima, U., Singh, I.K., Singh, A., Atif, S.M., Hariprasad, G., Hasan, G.M., and Hassan, M.I. (2020). Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim. Biophys. Acta Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165878"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tao, K., Tzou, P.L., Nouhin, J., Bonilla, H., Jagannathan, P., and Shafer, R.W. (2021). SARS-CoV-2 Antiviral Therapy. Clin. Microbiol. Rev., 34.","DOI":"10.1128\/CMR.00109-21"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Chatterjee, P., Ponnapati, M., Kramme, C., Plesa, A.M., Church, G.M., and Jacobson, J.M. (2020). Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions. Commun. Biol., 3.","DOI":"10.1038\/s42003-020-01470-7"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1080\/07391102.2021.1953601","article-title":"Protein degradation: A novel computational approach to design protein degrader probes for main protease of SARS-CoV-2","volume":"40","author":"Shaheer","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"De Jes\u00fas-Gonz\u00e1lez, L.A., Le\u00f3n-Ju\u00e1rez, M., Lira-Hern\u00e1ndez, F.I., Rivas-Santiago, B., Vel\u00e1zquez-Cervantes, M.A., M\u00e9ndez-Delgado, I.M., Mac\u00edas-Guerrero, D.I., Hern\u00e1ndez-Castillo, J., Hern\u00e1ndez-Rodr\u00edguez, X., and Calder\u00f3n-Sandate, D.N. (2025). Advances and Challenges in Antiviral Development for Respiratory Viruses. Pathogens, 14.","DOI":"10.3390\/pathogens14010020"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hajjo, R., Sabbah, D.A., Abusara, O.H., Kharmah, R., and Bardaweel, S. (2023). Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases. Viruses, 15.","DOI":"10.3390\/v15020568"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"\u0141ukasik, P., Za\u0142uski, M., and Gutowska, I. (2021). Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development\u2013Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062935"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/JVI.03176-12","article-title":"Influenza A virus NS1 induces G0\/G1 cell cycle arrest by inhibiting the expression and activity of RhoA protein","volume":"87","author":"Jiang","year":"2013","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Sui, L., Li, L., Zhao, Y., Zhao, Y., Hao, P., Guo, X., Wang, W., Wang, G., Li, C., and Liu, Q. (2023). Host cell cycle checkpoint as antiviral target for SARS-CoV-2 revealed by integrative transcriptome and proteome analyses. Sig Transduct. Target. Ther., 8.","DOI":"10.1038\/s41392-022-01296-1"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.tim.2021.01.014","article-title":"Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics","volume":"29","author":"Felip","year":"2021","journal-title":"Trends Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Riyaz Tramboo, S., Elkhalifa, A.M.E., Quibtiya, S., Ali, S.I., Nazir Shah, N., Taifa, S., Rakhshan, R., Hussain Shah, I., Ahmad Mir, M., and Malik, M. (2024). The critical impacts of cytokine storms in respiratory disorders. Heliyon, 10.","DOI":"10.1016\/j.heliyon.2024.e29769"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Li, H., Yang, W., Li, H., Bai, X., Zhang, H., Fan, W., Liu, W., and Sun, L. (2023). PROTAC targeting cyclophilin A controls virus-induced cytokine storm. iScience, 26.","DOI":"10.1016\/j.isci.2023.107535"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ghattas, M., Dwivedi, G., Lavertu, M., and Alameh, M.-G. (2021). Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities. Vaccines, 9.","DOI":"10.3390\/vaccines9121490"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Groenke, N., Trimpert, J., Merz, S., Conradie, A.M., Wyler, E., Zhang, H., Hazapis, O.-G., Rausch, S., Landthaler, M., and Osterrieder, N. (2020). Mechanism of Virus Attenuation by Codon Pair Deoptimization. Cell Rep., 31.","DOI":"10.1016\/j.celrep.2020.107586"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wang, T.Y., Meng, F.D., Sang, G.J., Zhang, H.L., Tian, Z.J., Zheng, H., Cai, X.H., and Tang, Y.D. (2023). A novel viral vaccine platform based on engineered transfer RNA. Emerg. Microbes Infect., 12.","DOI":"10.1080\/22221751.2022.2157339"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/2326-6066.CIR-23-1075","article-title":"Hyper-Interferon Sensitive Influenza Induces Adaptive Immune Responses and Overcomes Resistance to Anti-PD-1 in Murine Non-Small Cell Lung Cancer","volume":"12","author":"Du","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Subbarao, K. (2021). Live Attenuated Cold-Adapted Influenza Vaccines. Cold Spring Harb. Perspect. Med., 11.","DOI":"10.1101\/cshperspect.a038653"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Antia, R., Ahmed, H., and Bull, J.J. (2021). Directed attenuation to enhance vaccine immunity. PLoS Comput. Biol., 17.","DOI":"10.1371\/journal.pcbi.1008602"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Li, Z., Bai, H., Xi, X., Tian, W., Zhang, J.Z.H., Zhou, D., and Si, L. (2022). PROTAC vaccine: A new way to live attenuated vaccines. Clin. Transl. Med., 12.","DOI":"10.1002\/ctm2.1081"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41587-022-01381-4","article-title":"Generation of a live attenuated influenza A vaccine by proteolysis targeting","volume":"40","author":"Si","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41564-024-01908-2","article-title":"Proteolysis-targeting influenza vaccine strains induce broad-spectrum immunity and in vivo protection","volume":"10","author":"Shen","year":"2025","journal-title":"Nat. Microbiol."},{"key":"ref_56","unstructured":"(2025, April 04). PROTAR Vaccine 2.0 Generates Influenza Vaccines by Degrading Multiple Viral Proteins|Nature Chemical Biology. Available online: https:\/\/www.nature.com\/articles\/s41589-024-01813-z."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"D1510","DOI":"10.1093\/nar\/gkae768","article-title":"PROTAC-DB 3.0: An updated database of PROTACs with extended pharmacokinetic parameters","volume":"53","author":"Ge","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Li, F., Hu, Q., Zhou, Y., Yang, H., and Bai, F. (2024). DiffPROTACs is a deep learning-based generator for proteolysis targeting chimeras. Brief. Bioinform., 25.","DOI":"10.1093\/bib\/bbae358"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Li, F., Hu, Q., Zhang, X., Sun, R., Liu, Z., Wu, S., Tian, S., Ma, X., Dai, Z., and Yang, X. (2022). DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs. Nat. Commun., 13.","DOI":"10.1038\/s41467-022-34807-3"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/acscentsci.6b00280","article-title":"Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras","volume":"2","author":"Lebraud","year":"2016","journal-title":"ACS Cent. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1039\/D3NR06059D","article-title":"Nano-PROTACs: State of the art and perspectives","volume":"16","author":"Zhong","year":"2024","journal-title":"Nanoscale"},{"key":"ref_62","unstructured":"(2024, October 15). Developing Antibody-Based PROTACs. Available online: https:\/\/www.nature.com\/articles\/d41573-022-00159-2."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.chembiol.2019.07.015","article-title":"RIBOTACs: Small Molecules Target RNA for Degradation","volume":"26","author":"Dey","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","article-title":"AUTACs: Cargo-Specific Degraders Using Selective Autophagy","volume":"76","author":"Takahashi","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/cmdc.202100393","article-title":"LYTACs: An Emerging Tool for the Degradation of Non-Cytosolic Proteins","volume":"16","author":"Ramadas","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41422-021-00546-1","article-title":"Beyond targeted protein degradation: LD\u00b7ATTECs clear cellular lipid droplets","volume":"31","author":"Lucy","year":"2021","journal-title":"Cell Res."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/7\/1557\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:03:16Z","timestamp":1760032996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/7\/1557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":66,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["microorganisms13071557"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms13071557","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}